← Back to Search

Other

Melatonin 5mg for Delirium (MICE Trial)

Phase 4
Waitlist Available
Research Sponsored by MICE Trial Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Non-ventilated Patients over the age of 65
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality

Eligible Conditions
  • Delirium
  • Melatonin

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Melatonin 5mgActive Control1 Intervention
This arm will be given 5mg tablets of Melatonin nightly for the duration of their hospital stay
Group II: Melatonin 3mgActive Control1 Intervention
This arm will be given 3mg tablets of Melatonin nightly for the duration of their hospital stay
Group III: PlaceboPlacebo Group1 Intervention
This arm will be given a Sucrose tablet nightly for the duration of their hospital stay

Find a Location

Who is running the clinical trial?

MICE Trial GroupLead Sponsor
~69 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top